These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 8053959)
21. Molecular recognition patterns of anti-topoisomerase I-antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation. Glaeser L; Henes J; Kötter I; Vogel W; Kanz L; Klein R Clin Exp Rheumatol; 2018; 36 Suppl 113(4):28-35. PubMed ID: 29465357 [TBL] [Abstract][Full Text] [Related]
22. HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies. Falkner D; Wilson J; Medsger TA; Morel PA Arthritis Rheum; 1998 Jan; 41(1):74-80. PubMed ID: 9433872 [TBL] [Abstract][Full Text] [Related]
23. IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis. Martínez-Cordero E; Trejo AP; León DE J Clin Lab Anal; 2009; 23(6):408-16. PubMed ID: 19927342 [TBL] [Abstract][Full Text] [Related]
24. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis. Hayakawa I; Hasegawa M; Takehara K; Sato S Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014 [TBL] [Abstract][Full Text] [Related]
25. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera. Kuwana M; Kaburaki J; Medsger TA; Wright TM Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110 [TBL] [Abstract][Full Text] [Related]
26. Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele. Morel PA; Chang HJ; Wilson JW; Conte C; Saidman SL; Bray JD; Tweardy DJ; Medsger TA Hum Immunol; 1994 Jun; 40(2):101-10. PubMed ID: 7928439 [TBL] [Abstract][Full Text] [Related]
27. Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway. Shen CY; Li KJ; Lai PH; Yu CL; Hsieh SC Clin Rheumatol; 2018 Mar; 37(3):749-756. PubMed ID: 28940121 [TBL] [Abstract][Full Text] [Related]
28. Heparin inhibits the interaction of DNA topoisomerase I/anti-topoisomerase I immune complexes with heparan sulfate on dermal fibroblasts. Arcand J; Robitaille G; Koenig M; Senécal JL; Raymond Y Arthritis Rheum; 2012 May; 64(5):1632-41. PubMed ID: 22095242 [TBL] [Abstract][Full Text] [Related]
29. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil]. Coelho Horimoto AM; da Costa IP Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063 [TBL] [Abstract][Full Text] [Related]
30. Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice. Hu PQ; Hurwitz AA; Oppenheim JJ J Rheumatol; 2007 Nov; 34(11):2243-52. PubMed ID: 17937466 [TBL] [Abstract][Full Text] [Related]
31. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis. Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347 [TBL] [Abstract][Full Text] [Related]
32. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486 [TBL] [Abstract][Full Text] [Related]
33. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study. Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292 [TBL] [Abstract][Full Text] [Related]
34. Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis. Kuwana M; Kaburaki J; Mimori T; Kawakami Y; Tojo T Arthritis Rheum; 2000 May; 43(5):1074-84. PubMed ID: 10817562 [TBL] [Abstract][Full Text] [Related]
35. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies. Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258 [TBL] [Abstract][Full Text] [Related]
36. B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis. Rizou C; Ioannidis JP; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM; Vlachoyiannopoulos PG Am J Respir Cell Mol Biol; 2000 Mar; 22(3):344-51. PubMed ID: 10696071 [TBL] [Abstract][Full Text] [Related]
37. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study. Miyake M; Matsushita T; Takehara K; Hamaguchi Y Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135 [TBL] [Abstract][Full Text] [Related]
38. Molecular recognition patterns of serum anti-DNA topoisomerase I antibody in systemic sclerosis. Hu PQ; Fertig N; Medsger TA; Wright TM J Immunol; 2004 Aug; 173(4):2834-41. PubMed ID: 15295002 [TBL] [Abstract][Full Text] [Related]
39. Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome. Bankamp L; Preuß B; Pecher AC; Vogel W; Henes J; Klein R Rheumatology (Oxford); 2023 Jun; 62(6):2168-2177. PubMed ID: 36222553 [TBL] [Abstract][Full Text] [Related]
40. Serological profile of patients with systemic sclerosis. Wielosz E; Dryglewska M; Majdan M Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]